Skip to main content
. 2015 Oct 26;10:216. doi: 10.1186/s13014-015-0525-2

Table 3.

Clinical outcomes

Endpoint Time (months)
 Median follow-up 11.3
 Median survival 13.2
 Radiation necrosis
 Mean 10.9
 Median 11.0
Local intracranial progression
 Mean 5.59
Distant intracranial progression
 Mean 6.9
 Median 6.41
Dexamethasone Dose (mg/day)
 Median pre-SRS 10 mg/day
 Median post-SRS 0 mg/day
1-year outcomes % Survival
 1-year overall survival 45 %
 1-year local control 90 %